Eisai-Biogen to advance Alzheimer's drug, provide fresh hope

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer’s disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy.

from Reuters: Health News https://ift.tt/2Lw7WJb